chr11-95923947-T-G
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_016156.6(MTMR2):āc.8A>Cā(p.Lys3Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.355 in 1,557,506 control chromosomes in the GnomAD database, including 103,642 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. K3R) has been classified as Uncertain significance.
Frequency
Consequence
NM_016156.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MTMR2 | NM_016156.6 | c.8A>C | p.Lys3Thr | missense_variant | 1/15 | ENST00000346299.10 | |
MTMR2 | NM_001243571.2 | c.-476A>C | 5_prime_UTR_variant | 1/18 | |||
MTMR2 | NM_201278.3 | c.-403A>C | 5_prime_UTR_variant | 1/17 | |||
MTMR2 | NM_201281.3 | c.-280A>C | 5_prime_UTR_variant | 1/16 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MTMR2 | ENST00000346299.10 | c.8A>C | p.Lys3Thr | missense_variant | 1/15 | 1 | NM_016156.6 | P3 |
Frequencies
GnomAD3 genomes AF: 0.284 AC: 43157AN: 152070Hom.: 7358 Cov.: 33
GnomAD3 exomes AF: 0.288 AC: 46351AN: 160886Hom.: 7852 AF XY: 0.288 AC XY: 24838AN XY: 86292
GnomAD4 exome AF: 0.362 AC: 509240AN: 1405318Hom.: 96282 Cov.: 47 AF XY: 0.357 AC XY: 247845AN XY: 693846
GnomAD4 genome AF: 0.284 AC: 43159AN: 152188Hom.: 7360 Cov.: 33 AF XY: 0.275 AC XY: 20474AN XY: 74404
ClinVar
Submissions by phenotype
Charcot-Marie-Tooth disease type 4B1 Benign:4
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Jun 02, 2017 | - - |
Benign, criteria provided, single submitter | clinical testing | Mendelics | May 28, 2019 | - - |
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Sep 05, 2021 | - - |
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 03, 2015 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Charcot-Marie-Tooth disease Benign:1
Benign, criteria provided, single submitter | clinical testing | Molecular Genetics Laboratory, London Health Sciences Centre | - | - - |
Charcot-Marie-Tooth disease type 4 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at